Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beattie, G. M.
Right arrow Articles by Hayek, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beattie, G. M.
Right arrow Articles by Hayek, A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:3435-3439, 2002
© 2002 by the American Diabetes Association, Inc.

A Novel Approach to Increase Human Islet Cell Mass While Preserving ß-Cell Function

Gillian M. Beattie1, Anthony M.P. Montgomery1, Ana D. Lopez1, Ergeng Hao1, Brandon Perez1, Margaret L. Just1, Jonathan R.T. Lakey2, Marquis E. Hart1, and Alberto Hayek1

1 Department of Pediatrics and Surgery, The Whittier Institute, University of California at San Diego, La Jolla, California
2 Surgical Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada

Human islet expansion in monolayer culture leads to loss of function and senescence. By maintaining the 3-D configuration of islets in fibrin gels, it is feasible to expand ß-cells in response to hepatocyte growth factor (HGF) while preserving physiologic glucose responsiveness both in vitro and in vivo after transplantation into nude mice. Islets were cultured free floating with or without growth factors and nicotinamide and in fibrin gels with the same conditions. Proliferation was observed only in islets cultured in fibrin gels and the cocktail; total insulin increased by threefold, with a concomitant increase in ß-cell mass by morphometry. Insulin release after glucose challenge was also preserved. Islets in fibrin gels gave rise in vivo to large grafts rich in insulin and glucagon, and grafts from free-floating islets were smaller with fewer endocrine cells. Circulating human C-peptide levels were higher than in the mice receiving free-floating islets. In summary, fibrin allows for HGF-mediated cell proliferation while preserving glucose responsiveness in an environment that preserves cell-cell contacts. Limited islet ex vivo expansion under these conditions may improve recipient-donor tissue ratios to equal the functional results of whole-organ transplants.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
Y. Bar, H. A. Russ, S. Knoller, L. Ouziel-Yahalom, and S. Efrat
HES-1 Is Involved in Adaptation of Adult Human {beta}-Cells to Proliferation In Vitro
Diabetes, September 1, 2008; 57(9): 2413 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. A. Russ, Y. Bar, P. Ravassard, and S. Efrat
In Vitro Proliferation of Cells Derived From Adult Human {beta}-Cells Revealed By Cell-Lineage Tracing
Diabetes, June 1, 2008; 57(6): 1575 - 1583.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Weinberg, L. Ouziel-Yahalom, S. Knoller, S. Efrat, and Y. Dor
Lineage Tracing Evidence for In Vitro Dedifferentiation but Rare Proliferation of Mouse Pancreatic {beta}-Cells
Diabetes, May 1, 2007; 56(5): 1299 - 1304.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Mussmann, M. Geese, F. Harder, S. Kegel, U. Andag, A. Lomow, U. Burk, D. Onichtchouk, C. Dohrmann, and M. Austen
Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells
J. Biol. Chem., April 20, 2007; 282(16): 12030 - 12037.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Kaido, M. Yebra, V. Cirulli, C. Rhodes, G. Diaferia, and A. M. Montgomery
Impact of Defined Matrix Interactions on Insulin Production by Cultured Human {beta}-Cells: Effect on Insulin Content, Secretion, and Gene Transcription.
Diabetes, October 1, 2006; 55(10): 2723 - 2729.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
K. Shchors, E. Shchors, F. Rostker, E. R. Lawlor, L. Brown-Swigart, and G. I. Evan
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta
Genes & Dev., September 15, 2006; 20(18): 2527 - 2538.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Rao, J. Roccisana, K. K. Takane, R. Bottino, A. Zhao, M. Trucco, and A. Garcia-Ocana
Gene Transfer of Constitutively Active Akt Markedly Improves Human Islet Transplant Outcomes in Diabetic Severe Combined Immunodeficient Mice
Diabetes, June 1, 2005; 54(6): 1664 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Kaido, B. Perez, M. Yebra, J. Hill, V. Cirulli, A. Hayek, and A. M. Montgomery
{alpha}v-Integrin Utilization in Human {beta}-Cell Adhesion, Spreading, and Motility
J. Biol. Chem., April 23, 2004; 279(17): 17731 - 17737.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. J. Drucker
Glucagon-Like Peptide-1 and the Islet {beta}-Cell: Augmentation of Cell Proliferation and Inhibition of Apoptosis
Endocrinology, December 1, 2003; 144(12): 5145 - 5148.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.